Physical Activity on Prescription in Overweight Older Adults
|ClinicalTrials.gov Identifier: NCT02320760|
Recruitment Status : Completed
First Posted : December 19, 2014
Last Update Posted : December 19, 2014
This randomized controlled study evaluates the effect of individualized physical activity on prescription (PAP) in older overweight adults. The primary hypothesis is that an individualized prescription of physical activity increases physical activity level in overweight older adults after 6 months. Secondary hypothesis are that the increased physical activity level will improve cardio metabolic risk factors and quality of life.
200 women and men, aged 65 with low physical activity level, overweight, and abdominal obesity, will be randomized to an intervention group or a control group. The control group receives general information about physical activity and registration of physical activity level for one week. The intervention group receives in addition an individualized physical activity on prescription with patient-centered counseling.
After six months both groups go through the same health check-up as at baseline and follow-ups take place after 12 and 24 months.
|Condition or disease||Intervention/treatment||Phase|
|Low Physical Activity Level Central Obesity Metabolic Syndrome||Behavioral: Physical activity on prescription||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||102 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||Physical Activity in Prevention and Treatment of Overweight, Central Obesity and the Metabolic Syndrome - a Randomised Controlled Study in Overweight 65 Year Old Women and Men|
|Study Start Date :||January 2005|
|Actual Primary Completion Date :||January 2007|
|Actual Study Completion Date :||May 2009|
|Experimental: Physical activity on prescription||
Behavioral: Physical activity on prescription
|No Intervention: Ordinary care|
- physical activity level [ Time Frame: 6 months ]
- cardiometabolic risk factors [ Time Frame: 6 months ]
- Quality of life [ Time Frame: 6 months ]